Uterine Development During Induced Puberty in Girls with Turner Syndrome

ObjectiveMost girls and women with Turner syndrome (TS) require estrogen replacement therapy (ERT) to initiate or maintain pubertal development. Most likely, the most fundamental effect of ERT in hypogonadism is the promotion of uterine growth. The optimal ERT model is still being discussed. The pre...

Full description

Bibliographic Details
Main Authors: Monika Obara-Moszynska, Lukasz Dzialach, Barbara Rabska-Pietrzak, Marek Niedziela, Karina Kapczuk
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.707031/full
id doaj-e7403c0b4f6e4cc1830ae53c2c1eebc5
record_format Article
spelling doaj-e7403c0b4f6e4cc1830ae53c2c1eebc52021-07-06T14:08:29ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922021-07-011210.3389/fendo.2021.707031707031Uterine Development During Induced Puberty in Girls with Turner SyndromeMonika Obara-Moszynska0Lukasz Dzialach1Barbara Rabska-Pietrzak2Marek Niedziela3Karina Kapczuk4Karina Kapczuk5Department of Paediatric Endocrinology and Rheumatology, Institute of Pediatrics, Poznan University of Medical Sciences, Poznan, PolandStudent Scientific Society of Paediatric Endocrinology, Poznan University of Medical Sciences, Poznan, PolandDepartment of Paediatric Endocrinology and Rheumatology, Institute of Pediatrics, Poznan University of Medical Sciences, Poznan, PolandDepartment of Paediatric Endocrinology and Rheumatology, Institute of Pediatrics, Poznan University of Medical Sciences, Poznan, PolandDepartment of Paediatric Endocrinology and Rheumatology, Institute of Pediatrics, Poznan University of Medical Sciences, Poznan, PolandDepartment of Gynaecology, Poznan University of Medical Sciences, Poznan, PolandObjectiveMost girls and women with Turner syndrome (TS) require estrogen replacement therapy (ERT) to initiate or maintain pubertal development. Most likely, the most fundamental effect of ERT in hypogonadism is the promotion of uterine growth. The optimal ERT model is still being discussed. The present study aimed to assess uterine size in girls with TS in the prepubertal state during and after the induction of puberty and compare it to a healthy population.MethodsThe analysis encompassed 40 TS girls. The prepubertal and postpubertal control groups contained 20 healthy girls each. All patients with TS were treated with 17-ß estradiol. Uterine imaging was performed with two-dimensional (2D) transabdominal ultrasound. The uterine volume (UV) and fundocervical antero-posterior ratio (FCR) were calculated in patients with TS before the pubertal induction, after 6-12 months of estrogen replacement therapy (ERT), after ≥ 36 months of ERT or ≥ 12 months after menarche.ResultsThe average age of TS patients at estrogen introduction and at the last control visit, when the uterus was considered mature, was 12.9 years and 16.1 years, respectively. The UV in patients with TS at the beginning of ERT was 1.55 ± 1.22 cm3 and was not significantly different from the UV in the prepubertal controls. The mature UV in patients with TS was 31.04 ± 11.78 cm3 and was significantly smaller than the UV of the postpubertal controls (45.68 ± 12.51 cm3, p<0.001). The FCR in girls with TS did not differ significantly from that in the prepubertal and postpubertal control groups, respectively. No prognostic factors could be established for the final UV. By the last control visit, thelarche had advanced in most patients to Tanner 4 and 5 (37.5% and 40%, respectively).ConclusionsBefore the onset of ERT, patients with TS have a uterus similar in size to that in prepubertal healthy girls. Pubertal induction in patients with TS causes a significant increase in the UV that is detectable after 6-12 months of ERT. The mature uterus is smaller in patients with TS than in the age-matched healthy population.https://www.frontiersin.org/articles/10.3389/fendo.2021.707031/fullTurner syndromepuberty inductionuterine developmentuterine volumeestrogen therapy
collection DOAJ
language English
format Article
sources DOAJ
author Monika Obara-Moszynska
Lukasz Dzialach
Barbara Rabska-Pietrzak
Marek Niedziela
Karina Kapczuk
Karina Kapczuk
spellingShingle Monika Obara-Moszynska
Lukasz Dzialach
Barbara Rabska-Pietrzak
Marek Niedziela
Karina Kapczuk
Karina Kapczuk
Uterine Development During Induced Puberty in Girls with Turner Syndrome
Frontiers in Endocrinology
Turner syndrome
puberty induction
uterine development
uterine volume
estrogen therapy
author_facet Monika Obara-Moszynska
Lukasz Dzialach
Barbara Rabska-Pietrzak
Marek Niedziela
Karina Kapczuk
Karina Kapczuk
author_sort Monika Obara-Moszynska
title Uterine Development During Induced Puberty in Girls with Turner Syndrome
title_short Uterine Development During Induced Puberty in Girls with Turner Syndrome
title_full Uterine Development During Induced Puberty in Girls with Turner Syndrome
title_fullStr Uterine Development During Induced Puberty in Girls with Turner Syndrome
title_full_unstemmed Uterine Development During Induced Puberty in Girls with Turner Syndrome
title_sort uterine development during induced puberty in girls with turner syndrome
publisher Frontiers Media S.A.
series Frontiers in Endocrinology
issn 1664-2392
publishDate 2021-07-01
description ObjectiveMost girls and women with Turner syndrome (TS) require estrogen replacement therapy (ERT) to initiate or maintain pubertal development. Most likely, the most fundamental effect of ERT in hypogonadism is the promotion of uterine growth. The optimal ERT model is still being discussed. The present study aimed to assess uterine size in girls with TS in the prepubertal state during and after the induction of puberty and compare it to a healthy population.MethodsThe analysis encompassed 40 TS girls. The prepubertal and postpubertal control groups contained 20 healthy girls each. All patients with TS were treated with 17-ß estradiol. Uterine imaging was performed with two-dimensional (2D) transabdominal ultrasound. The uterine volume (UV) and fundocervical antero-posterior ratio (FCR) were calculated in patients with TS before the pubertal induction, after 6-12 months of estrogen replacement therapy (ERT), after ≥ 36 months of ERT or ≥ 12 months after menarche.ResultsThe average age of TS patients at estrogen introduction and at the last control visit, when the uterus was considered mature, was 12.9 years and 16.1 years, respectively. The UV in patients with TS at the beginning of ERT was 1.55 ± 1.22 cm3 and was not significantly different from the UV in the prepubertal controls. The mature UV in patients with TS was 31.04 ± 11.78 cm3 and was significantly smaller than the UV of the postpubertal controls (45.68 ± 12.51 cm3, p<0.001). The FCR in girls with TS did not differ significantly from that in the prepubertal and postpubertal control groups, respectively. No prognostic factors could be established for the final UV. By the last control visit, thelarche had advanced in most patients to Tanner 4 and 5 (37.5% and 40%, respectively).ConclusionsBefore the onset of ERT, patients with TS have a uterus similar in size to that in prepubertal healthy girls. Pubertal induction in patients with TS causes a significant increase in the UV that is detectable after 6-12 months of ERT. The mature uterus is smaller in patients with TS than in the age-matched healthy population.
topic Turner syndrome
puberty induction
uterine development
uterine volume
estrogen therapy
url https://www.frontiersin.org/articles/10.3389/fendo.2021.707031/full
work_keys_str_mv AT monikaobaramoszynska uterinedevelopmentduringinducedpubertyingirlswithturnersyndrome
AT lukaszdzialach uterinedevelopmentduringinducedpubertyingirlswithturnersyndrome
AT barbararabskapietrzak uterinedevelopmentduringinducedpubertyingirlswithturnersyndrome
AT marekniedziela uterinedevelopmentduringinducedpubertyingirlswithturnersyndrome
AT karinakapczuk uterinedevelopmentduringinducedpubertyingirlswithturnersyndrome
AT karinakapczuk uterinedevelopmentduringinducedpubertyingirlswithturnersyndrome
_version_ 1721317368264654848